Nuance Pharma Announces Approval of Ohtuvayre™ (ensifentrine) in Macau SAR, China - Thailand PR News - [Banking](https://thailandbusinessnews.net/category/banking/) - [Companies](https://thailandbusinessnews.net/category/companies/) - [Economy](https://thailandbusinessnews.net/category/economy/) - [Press Releases](https://thailandbusinessnews.net/category/press-release/) - [PR Newswire](https://thailandbusinessnews.net/pr-newswire-updates/) - [Tech](https://thailandbusinessnews.net/category/tech/) - [Tourism](https://thailandbusinessnews.net/category/tourism/) - [Press Release](https://thailandbusinessnews.net/category/press-release/) # Nuance Pharma Announces Approval of Ohtuvayre™ (ensifentrine) in Macau SAR, China ##### Up next ###### [TIER IV, Nihon Kotsu launch data collection project to enhance autonomous driving AI](https://thailandbusinessnews.net/press-release/tier-iv-nihon-kotsu-launch-data-collection-project-to-enhance-autonomous-driving-ai/) Published on 07 February 2025 ##### Author ##### [ CISION PRNewswire ](https://thailandbusinessnews.net/author/cision/) ##### Tags - [PRNewswire](https://thailandbusinessnews.net/tag/prnewswire/) Ohtuvayre™is indicated for the maintenance treatment of chronic obstructive pulmonary disease (COPD) in adult patients First inhaled COPD treatment providing bronchodilation and non-steroidal anti-inflammatory effects SHANGHAI, Feb. 7, 2025 /PRNewswire/ — Today, Nuance Pharma ("Nuance") announced that the Pharmaceutical Administration Bureau Macau approved Ohtuvayre™ (ensifentrine) for the maintenance treatment of chronic obstructive pulmonary disease (COPD) in adult patients. In June 2024, Ohtuvayre™ was approved in the United States and became commercially available in August. Ohtuvayre™ is a first-in-class selective dual inhibitor of phosphodiesterase 3 and 4 ("PDE3; PDE4") that combines bronchodilator and non-steroidal anti-inflammatory effects in one molecule, delivered directly to the lungs through a standard jet nebulizer without the need for high inspiratory flow rates or complex hand-breath coordination. The approval of Ohtuvayre™ in Macau SAR, China, was based on extensive data including the Global Phase 3 ENHANCE trials, the results of which were published in the American Journal of Respiratory and Critical Care Medicine. In the ENHANCE trials, OhtuvayreTM demonstrated clinical benefits both alone and when used with other maintenance therapies. OhtuvayreTM was well-tolerated in a broad population of subjects with moderate to severe COPD. Mark Lotter, founder and Chief Executive Officer of Nuance Pharma, said: "We are pleased to announce that the Macau regulatory authority has approved the NDA of Ohtuvayre™, which also marks the first regulatory approval outside of the US. We are proud to provide access to this highly innovative COPD treatment to patients in Macau and beyond, for example through innovative policy in the Greater Bay Area (GBA). Respiratory disease is among Nuance’s core areas of focus, and through approval in Macao SAR and early access programs in Hainan BoAo and GBA, Nuance Pharma is looking forward to providing this novel, first-in-class treatment to patients in China, prior to our expected NDA submission in 2025 upon completion of the ENHANCE-CHINA trial." David Zaccardelli, Pharm. D., President and Chief Executive Officer of Verona Pharma, said: "We are very pleased that OhtuvayreTM is available to help patients still experiencing daily COPD symptoms. We are encouraged by the initial impact of OhtuvayreTM and believe its novel profile can re-define the COPD treatment paradigm." In Nov 2024, Nuance Pharma launched Ohtuvayre™ in China’s Hainan Boao Pilot Zone through early access program. In Sep 2024, Nuance Pharma completed recruitment for ENHANCE-CHINA, the phase 3 clinical trial of ensifentrine for the maintenance treatment of COPD. In 2021, Nuance Pharma entered into an agreement with Verona Pharma for the exclusive rights to develop and commercialize Ohtuvayre™ in Greater China (mainland China, Hong Kong, Macau and Taiwan). About Ohtuvayre™ (ensifentrine) Ohtuvayre™ is the first inhaled therapy for the maintenance treatment of COPD that combines bronchodilator and non-steroidal anti-inflammatory activities in one molecule. Verona has evaluated nebulized Ohtuvayre™ in its Phase 3 clinical program ENHANCE ("Ensifentrine as a Novel inHAled Nebulized COPD thErapy") for COPD maintenance treatment. Ohtuvayre™ met the primary endpoint in both ENHANCE-1 and ENHANCE-2, demonstrating statistically significant and clinically meaningful improvements in lung function. About Verona Pharma Verona Pharma is a biopharmaceutical company focused on developing and commercializing innovative therapies for the treatment of chronic respiratory diseases with significant unmet medical needs. OhtuvayreTM (ensifentrine) is the Company’s first commercial product and the first inhaled therapy for the maintenance treatment of COPD that combines bronchodilator and non-steroidal anti-inflammatory activities in one molecule. Ensifentrine has potential applications in non-cystic fibrosis bronchiectasis, cystic fibrosis, asthma and other respiratory diseases. For more information, please visit [www.veronapharma.com](https://www.veronapharma.com/). About Nuance Pharma Nuance Pharma is an innovation focused biopharmaceutical company, with both late-stage clinical pipeline and commercial stage asset portfolio. Focusing on specialty care, Nuance has established a differentiated combination of commercialized assets and innovative pipeline across respiratory, pain management, emergency care and iron deficiency anemia. With the mission to address critical unmet medical needs in Asia Pacific, Nuance deploys the Dual Wheel model that develops a global leading innovative pipeline, while maintaining a self-sustainable commercial operation in both China and Asia as a region. For more information, please visit [www.nuancepharma.com](https://www.nuancepharma.com). Forward-looking Statements This news release may make statements that constitute forward-looking statements, including descriptions regarding the intent, belief or current expectations of the Company or its officers with respect to the business operations and financial condition of the Company, which can be identified by terminology such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates," "confident" and similar statements. Such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, or other factors, some of which are beyond the control of the Company and are unforeseeable. Therefore, the actual results may differ from those in the forward-looking statements as a result of various factors and assumptions, such as future changes and developments in our business, competitive environment, political, economic, legal and social conditions. The Company or any of its affiliates, directors, officers, advisors or representatives has no obligation and does not undertake to revise forward-looking statements to reflect new information, future events or circumstances after the date of this news release, except as required by law. [Source link ](https://www.prnasia.com/story/archive/4613263_AE13263_0?rand=89749) ``` This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network ``` ##### You May Also Like [](https://thailandbusinessnews.net/press-release/yy-group-launches-bursary-award-for-gig-workers-pursuing-higher-education/) ![YY Group Launches Bursary Award for Gig Workers Pursuing Higher Education](https://i0.wp.com/r2.thailandbusinessnews.net/2025/10/YY_Group_Bursary_Award.jpg?resize=260%2C140&ssl=1 "YY Group Launches Bursary Award for Gig Workers Pursuing Higher Education") - [Press Release](https://thailandbusinessnews.net/category/press-release/) ## YY Group Launches Bursary Award for Gig Workers Pursuing Higher Education SINGAPORE, Oct. 13, 2025 /PRNewswire/ — YY Group Holding Limited (NASDAQ: YYGH)… - [CISION PRNewswire](https://thailandbusinessnews.net/author/cision/ "View all posts by CISION PRNewswire") - October 13, 2025 [](https://thailandbusinessnews.net/press-release/clodura-ai-launches-atlas-an-ai-native-sdr-that-replaces-the-fragmented-outbound-stack/) ![Clodura.AI Launches Atlas, an AI-Native SDR that Replaces the Fragmented Outbound Stack](https://i0.wp.com/mma.prnasia.com/media2/2954758/Clodura_AI_Atlas.jpg?resize=260%2C140&ssl=1 "Clodura.AI Launches Atlas, an AI-Native SDR that Replaces the Fragmented Outbound Stack") - [Press Release](https://thailandbusinessnews.net/category/press-release/) ## Clodura.AI Launches Atlas, an AI-Native SDR that Replaces the Fragmented Outbound Stack Powered by continuously refreshed verified data across 600M+ contacts, Atlas unifies data,… - [CISION PRNewswire](https://thailandbusinessnews.net/author/cision/ "View all posts by CISION PRNewswire") - April 14, 2026 [](https://thailandbusinessnews.net/press-release/phemex-launches-6-million-multi-venue-festival-to-celebrate-its-6th-anniversary/) ![Phemex Launches Million, Multi-Venue Festival to Celebrate Its 6th Anniversary](https://i0.wp.com/r2.thailandbusinessnews.net/2025/11/1763548068_Phemex_Logo.jpg?resize=260%2C140&ssl=1 "Phemex Launches Million, Multi-Venue Festival to Celebrate Its 6th Anniversary") - [Press Release](https://thailandbusinessnews.net/category/press-release/) ## Phemex Launches $6 Million, Multi-Venue Festival to Celebrate Its 6th Anniversary APIA, Samoa, Nov. 19, 2025 /PRNewswire/ — Phemex, a user-first crypto exchange, announces… - [CISION PRNewswire](https://thailandbusinessnews.net/author/cision/ "View all posts by CISION PRNewswire") - November 19, 2025 ##### Most Read - [![DORCO Tinkle Is Awarded with 2026 IDEA Finalist for Brand Renewal](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/dorco-tinkle-is-awarded-with-2026-idea-finalist-for-brand-renewal/ "DORCO Tinkle Is Awarded with 2026 IDEA Finalist for Brand Renewal") [DORCO Tinkle Is Awarded with 2026 IDEA Finalist for Brand Renewal](https://thailandbusinessnews.net/press-release/dorco-tinkle-is-awarded-with-2026-idea-finalist-for-brand-renewal/ "DORCO Tinkle Is Awarded with 2026 IDEA Finalist for Brand Renewal") - [![Priority Pass to accelerate travel innovation, backed by the Collinson Group's £500 million growth programme](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/priority-pass-to-accelerate-travel-innovation-backed-by-the-collinson-groups-500-million-growth-programme-2/ "Priority Pass to accelerate travel innovation, backed by the Collinson Group's £500 million growth programme") [Priority Pass to accelerate travel innovation, backed by the Collinson Group's £500 million growth programme](https://thailandbusinessnews.net/press-release/priority-pass-to-accelerate-travel-innovation-backed-by-the-collinson-groups-500-million-growth-programme-2/ "Priority Pass to accelerate travel innovation, backed by the Collinson Group's £500 million growth programme") - [![DORCO Wins 2026 Red Dot Award for Renewed Corporate Identity](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/dorco-wins-2026-red-dot-award-for-renewed-corporate-identity/ "DORCO Wins 2026 Red Dot Award for Renewed Corporate Identity") [DORCO Wins 2026 Red Dot Award for Renewed Corporate Identity](https://thailandbusinessnews.net/press-release/dorco-wins-2026-red-dot-award-for-renewed-corporate-identity/ "DORCO Wins 2026 Red Dot Award for Renewed Corporate Identity") - [![Dragonpass: AI Is Shifting the Membership Economy from Perks Redemption to Personalized Experiences](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/dragonpass-ai-is-shifting-the-membership-economy-from-perks-redemption-to-personalized-experiences/ "Dragonpass: AI Is Shifting the Membership Economy from Perks Redemption to Personalized Experiences") [Dragonpass: AI Is Shifting the Membership Economy from Perks Redemption to Personalized Experiences](https://thailandbusinessnews.net/press-release/dragonpass-ai-is-shifting-the-membership-economy-from-perks-redemption-to-personalized-experiences/ "Dragonpass: AI Is Shifting the Membership Economy from Perks Redemption to Personalized Experiences") - [![Modern Meadow and Bellroy Partner on Carry Products Made of Next-Generation Material](https://i0.wp.com/r2.thailandbusinessnews.net/2025/04/MODERN_MEADOW_LOGO_BLACK_PNG_Logo.jpg?fit=597%2C138&ssl=1&resize=40%2C40)](https://thailandbusinessnews.net/press-release/modern-meadow-and-bellroy-partner-on-carry-products-made-of-next-generation-material/ "Modern Meadow and Bellroy Partner on Carry Products Made of Next-Generation Material") [Modern Meadow and Bellroy Partner on Carry Products Made of Next-Generation Material](https://thailandbusinessnews.net/press-release/modern-meadow-and-bellroy-partner-on-carry-products-made-of-next-generation-material/ "Modern Meadow and Bellroy Partner on Carry Products Made of Next-Generation Material") - [![Tamarind Health launches Rare Cancer Centre to make specialist expertise easier to access](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/tamarind-health-launches-rare-cancer-centre-to-make-specialist-expertise-easier-to-access/ "Tamarind Health launches Rare Cancer Centre to make specialist expertise easier to access") [Tamarind Health launches Rare Cancer Centre to make specialist expertise easier to access](https://thailandbusinessnews.net/press-release/tamarind-health-launches-rare-cancer-centre-to-make-specialist-expertise-easier-to-access/ "Tamarind Health launches Rare Cancer Centre to make specialist expertise easier to access") ##### Subscribe via Email Enter your email address to subscribe and receive notifications of new posts by email. Email Address Subscribe [](https://thailandbusinessnews.net/press-release/peka-b40-screenings-reveal-undiagnosed-conditions-among-almost-half-of-participants/) ![PeKa B40 Screenings Reveal Undiagnosed Conditions Among Almost Half of Participants](https://i0.wp.com/mmx.prnasia.com/media/MS2000518/20260930222228EDT_image_1.jpg?resize=260%2C140&ssl=1 "PeKa B40 Screenings Reveal Undiagnosed Conditions Among Almost Half of Participants") ## PeKa B40 Screenings Reveal Undiagnosed Conditions Among Almost Half of Participants STR recipients and their spouses aged 40 and above urged to use their… [](https://thailandbusinessnews.net/press-release/ibm-introduces-self-hosted-deployment-for-ibm-bob-to-help-enterprises-advance-ai-sovereignty-and-governance/) ![IBM Introduces Self-Hosted Deployment for IBM Bob to Help Enterprises Advance AI Sovereignty and Governance](https://i0.wp.com/mmx.prnasia.com/media/MS1836571/Bob-home-page-light-Banner.jpg?resize=260%2C140&ssl=1 "IBM Introduces Self-Hosted Deployment for IBM Bob to Help Enterprises Advance AI Sovereignty and Governance") ## IBM Introduces Self-Hosted Deployment for IBM Bob to Help Enterprises Advance AI Sovereignty and Governance Enterprises can now benefit from AI-powered software development and modernization… [](https://thailandbusinessnews.net/press-release/2026-world-manufacturing-convention-secures-790-agreements-worth-rmb-363-4-billion/) ![2026 World Manufacturing Convention Secures 790 Agreements Worth RMB 363.4 Billion](https://i0.wp.com/mmx.prnasia.com/media/MS2000478/20260930205124EDT_image1.jpg?resize=260%2C140&ssl=1 "2026 World Manufacturing Convention Secures 790 Agreements Worth RMB 363.4 Billion") ## 2026 World Manufacturing Convention Secures 790 Agreements Worth RMB 363.4 Billion HEFEI, China, Oct. 1, 2026 /PRNewswire/ — The 2026 World Manufacturing… [](https://thailandbusinessnews.net/press-release/jm-flower-introduces-grab-go-live-noble-fir-christmas-trees-for-the-2026-festive-season/) ## JM Flower Introduces Grab & Go Live Noble Fir Christmas Trees for the 2026 Festive Season New 5–6ft USA Noble Fir option offers a faster purchasing experience without…